Evolution and persistence of resistance-associated substitutions of hepatitis C virus after direct-acting antiviral treatment failures. [electronic resource]
- Journal of viral hepatitis 11 2018
- 1251-1259 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1365-2893
10.1111/jvh.12932 doi
Aged Antiviral Agents--therapeutic use Carbamates Cell Line, Tumor Drug Resistance, Viral--genetics Drug Therapy, Combination Female Genotype Hepacivirus--drug effects Hepatitis C, Chronic--drug therapy Humans Imidazoles--therapeutic use Isoquinolines--therapeutic use Male Middle Aged Mutation Pyrrolidines RNA, Viral--biosynthesis Sulfonamides--therapeutic use Treatment Failure Valine--analogs & derivatives Viral Nonstructural Proteins--genetics Virus Assembly--genetics Virus Replication--genetics